Cefozopran
Title: Cefozopran
CAS Registry Number: 113359-04-9
CAS Name: 1-[[(6R,7R)-7-[[(2Z)-(5-Amino-1,2,4-thiadiazol-3-yl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]imidazo[1,2-b]pyridazinium inner salt
Additional Names: 7b-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-methoxyiminoacetamido]-3-[(imidazo[1,2-b]pyridazinium-1-yl)methyl]-3-cephem-4-carboxylate
Molecular Formula: C19H17N9O5S2
Molecular Weight: 515.53
Percent Composition: C 44.27%, H 3.32%, N 24.45%, O 15.52%, S 12.44%
Literature References: Prepn: A. Miyake et al., WO 8605183; eidem, US 4864022 (1986, 1989 both to Takeda); A. Miyake et al., J. Antibiot. 45, 709 (1992). Antibacterial spectrum: T. Iwahi et al., Antimicrob. Agents Chemother. 36, 1358 (1992). In vivo activity: Y. Iizawa et al., ibid. 37, 100 (1993). Pharmacokinetics: W. Paulfeuerborn et al., ibid. 1835. HPLC determn in serum and urine: K. Borner, E. Borner, J. Chromatogr. 615, 174 (1993).
 
Derivative Type: Hydrochloride
Manufacturers' Codes: SCE-2787
Trademarks: Firstcin (Takeda)
Molecular Formula: C19H17N9O5S2.HCl
Molecular Weight: 551.99
Percent Composition: C 41.34%, H 3.29%, N 22.84%, O 14.49%, S 11.62%, Cl 6.42%
 
Therap-Cat: Antibacterial.
Keywords: Antibacterial (Antibiotics); ?Lactams; Cephalosporins.

Others monographs:
PirazolacFlumethiazideAzelaic AcidSodium Tartrate
Cryptenamine TannatesFenhexamidEuphorbiaStrobilurins
BikhaconitineLonazolacAloxidoneDemeton
Lactic Acid HomopolymerPolar® YellowHaloxazolamQuercimeritrin
©2016 DrugLead US FDA&EMEA